The tendency for TRβ expression to disappear as malignancies progress suggests that TRβ can act as a tumor suppressor in human cancers and that therefore loss of expression and/or function of this receptor could result in a selective advantage for cell transformation and tumor development [21]. The gene discussed is THRB; the disease is neoplasm.